Group One Trading
TGTX icon

Group One Trading’s TG Therapeutics TGTX Stock Holding History

Group One Trading’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.5M Sell
45,240
-183,267
-80% -$5.46M ﹤0.01% 2337
2025
Q4 		$6.81M Sell
228,507
-77,088
-25% -$2.52M 0.01% 1234
2025
Q3 		$11M Sell
305,595
-158,930
-34% -$5.24M 0.02% 845
2025
Q2 		$16.7M Buy
464,525
+162,891
+54% +$6.06M 0.04% 522
2025
Q1 		$11.9M Sell
301,634
-455,885
-60% -$15.3M 0.03% 548
2024
Q4 		$22.8M Buy
757,519
+139,150
+23% +$3.99M 0.05% 330
2024
Q3 		$14.5M Sell
618,369
-285
-0% -$6.22K 0.04% 422
2024
Q2 		$11M Buy
618,654
+10,372
+2% +$166K 0.04% 396
2024
Q1 		$9.25M Sell
608,282
-388,560
-39% -$6.19M 0.04% 478
2023
Q4 		$17M Buy
996,842
+339,803
+52% +$3.95M 0.04% 425
2023
Q3 		$5.49M Buy
657,039
+378,731
+136% +$5.28M 0.02% 891
2023
Q2 		$6.91M Sell
278,308
-23,881
-8% -$617K 0.02% 739
2023
Q1 		$4.54M Sell
302,189
-524,460
-63% -$7.97M 0.02% 897
2022
Q4 		$9.78M Sell
826,649
-336,402
-29% -$2.44M 0.02% 749
2022
Q3 		$6.88M Buy
1,163,051
+66,682
+6% +$437K 0.01% 942
2022
Q2 		$4.66M Sell
1,096,369
-723,175
-40% -$4.52M 0.01% 1347
2022
Q1 		$17.3M Sell
1,819,544
-59,534
-3% -$689K 0.02% 680
2021
Q4 		$35.7M Buy
1,879,078
+186,407
+11% +$4.84M 0.03% 413
2021
Q3 		$56.3M Buy
1,692,671
+794,981
+89% +$24.6M 0.06% 256
2021
Q2 		$34.8M Buy
897,690
+406,434
+83% +$16M 0.04% 371
2021
Q1 		$23.7M Buy
491,256
+325,630
+197% +$15.6M 0.04% 461
2020
Q4 		$8.62M Sell
165,626
-124,676
-43% -$4.21M 0.01% 903
2020
Q3 		$7.77M Buy
290,302
+162,210
+127% +$3.73M 0.02% 650
2020
Q2 		$2.5M Buy
128,092
+65,277
+104% +$1.05M 0.01% 1304
2020
Q1 		$618K Sell
62,815
-28,620
-31% -$361K 0.01% 1895
2019
Q4 		$1.01M Buy
91,435
+42,743
+88% +$325K 0.01% 1857
2019
Q3 		$273K Buy
+48,692
New +$339K ﹤0.01% 2856
2019
Q2 		– Sell
-109,826
Closed -$830K – 5386
2019
Q1 		$883K Sell
109,826
-36,208
-25% -$196K 0.01% 1502
2018
Q4 		$599K Buy
146,034
+389
+0.3% +$1.93K 0.01% 1879
2018
Q3 		$816K Sell
145,645
-52,404
-26% -$599K 0.01% 1868
2018
Q2 		$2.6M Buy
198,049
+16,572
+9% +$228K 0.02% 940
2018
Q1 		$2.58M Buy
181,477
+48,084
+36% +$614K 0.03% 827
2017
Q4 		$1.09M Buy
133,393
+38,711
+41% +$338K 0.01% 1629
2017
Q3 		$1.12M Sell
94,682
-29,281
-24% -$334K 0.01% 1468
2017
Q2 		$1.25M Buy
123,963
+88,474
+249% +$990K 0.01% 1287
2017
Q1 		$413K Buy
35,489
+30,435
+602% +$218K ﹤0.01% 1974
2016
Q4 		$24K Buy
5,054
+2,700
+115% +$15.8K ﹤0.01% 3634
2016
Q3 		$18K Buy
2,354
+1,200
+104% +$7.72K ﹤0.01% 3837
2016
Q2 		$7K Sell
1,154
-1,186
-51% -$9.64K ﹤0.01% 4193
2016
Q1 		$20K Sell
2,340
-32,646
-93% -$286K ﹤0.01% 3749
2015
Q4 		$417K Sell
34,986
-63,331
-64% -$800K ﹤0.01% 1964
2015
Q3 		$991K Buy
98,317
+37,383
+61% +$557K 0.01% 1251
2015
Q2 		$1.01M Buy
60,934
+25,214
+71% +$399K 0.01% 1197
2015
Q1 		$553K Buy
35,720
+21,472
+151% +$325K 0.01% 1514
2014
Q4 		$226K Sell
14,248
-31,784
-69% -$414K ﹤0.01% 2210
2014
Q3 		$491K Sell
46,032
-3,452
-7% -$32K 0.01% 1644
2014
Q2 		$465K Buy
49,484
+14,204
+40% +$90.8K 0.01% 1705
2014
Q1 		$243K Buy
35,280
+29,649
+527% +$175K ﹤0.01% 2279
2013
Q4 		$22K Buy
+5,631
New +$22.7K ﹤0.01% 4188

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Group One Trading's TGTX Position: Q1 2026 in Review

Group One Trading reduced its TG Therapeutics (TGTX) stake by 80% in Q1 2026, selling an estimated $5.46M and leaving 45,240 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2337.

Group One Trading first reported a position in TGTX in Q4 2013 and has held it in 49 quarters since. The position peaked at $56.3M in Q3 2021. 363 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.

  • Group One Trading held 45,240 shares of TG Therapeutics worth $1.5M as of Q1 2026.
  • Group One Trading sold 183,267 TG Therapeutics shares in Q1 2026, an estimated $5.46M.
  • TG Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #2337 holding.
  • Group One Trading first reported a position in TG Therapeutics in Q4 2013 and has held it in 49 quarters since.
  • Group One Trading's TG Therapeutics position peaked at $56.3M in Q3 2021.
  • 363 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.